Cb. Xu et al., A COMPARATIVE-STUDY OF INTRAVENOUS ACCELERATED STREPTOKINASE DOSE REGIMEN WITH CONVENTIONAL-DOSE REGIMEN FOR CORONARY THROMBOLYSIS, Chinese medical journal, 110(1), 1997, pp. 59-61
Recently, it has been reported that accelerated plasminogen activator
dose regimens for coronary thrombolysis improves reperfusion rate.(1)
Streptokinase (SK) has been widely used in Northern American and Europ
ean countries to treat acute myocardial infarction (AMI).(2-4) The con
ventional thrombolytic regimen was intravenous SK of 1.5 million units
within 60 min. However, accelerated SK dose regimen for AMI has not b
een reported. The aim of this study was to evaluate the patency rate a
nd safety of the accelerated SK dose regimen for coronary thrombolysis
compared with the conventional one.